
|Articles|January 26, 2004
FDA delays mandate on aluminum labeling in TPNs
FDA delays the date of effectiveness of its labeling requirements related to aluminum toxicity in total parenteral nutrition solutions
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Afibercept-Boav as Biosimilar to Afibercept for Diabetic Macular Edema
2
FDA Approves Risperidone Injection for Bipolar I Disorder in Adults
3
Vaccine Messaging for Teens Should Tailor to Personal Perspectives
4
American Pharmacists Month: Students Seeking Both Common, Non-Traditional Pharmacy Careers
5